Anesthesia & Clinical Research

Anesthesia & Clinical Research
Open Access

ISSN: 2155-6148

Research Article - (2017) Volume 8, Issue 11

Effectiveness of Intravenous Prophylactic Phenylephrine for the Prevention of Spinal Anaesthesia Induced Hypotension during Caesarean Section. A Prospective Observational Study

Abatneh Feleke Agegnehu, Amare Hailekiros Gebreegzi, Girmay Fitiwi Lemma, Nigussie Simeneh Endalew and Endale Gebreegziabher Gebremedhn*
Department of Anaesthesia, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Ethiopia
*Corresponding Author: Endale Gebreegziabher Gebremedhn, Department of Anaesthesia, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Ethiopia Email:

Abstract

Background: Hypotension is one of the common complications of spinal anaesthesia. It has many detrimental effects to the mother and fetus if left untreated. Recently, phenylephrine is introduced for the treatment of hypotension in our hospital. However, its efficacy on the prevention of spinal anaesthesia induced hypotension is still under controversy. We aimed to assess the effectiveness of phenylephrine prophylaxis on spinal hypotension after caesarean section.
Methods: A prospective observational study was conducted at the University of Gondar Hospital. Patients were allocated based on treatment received; 50/100 μgm phenylephrine prophylaxis vs. no prophylaxis. PR, SBP, DBP, SPO2 and APGAR score were measured before, immediately after spinal anaesthesia, every 2 min intra operatively till the delivery of the baby and every 5 min after delivery for 20 min, and every 10 min for 1 h in postoperative period.
Results: The incidence of hypotension was significantly lower for those participants with prophylactic phenylephrine (26% vs. 81.6%, p<0.001) compared to the non-treatment group. Systolic and diastolic blood pressures immediately after spinal anaesthesia till delivery and after delivery of the baby were significantly lower in the none treatment group at all times (p<0.05). Moreover, the number of rescue treatments and total amount of fluid given during the intraoperative period for the treatment of hypotension were more in the non-treatment group P=0.001). The APGAR scores at 1 and 5 min and postoperative vital signs were comparable between groups.
Conclusion and recommendation: The incidence of spinal anaesthesia induced hypotension was high. Prophylactic intravenous phenylephrine bolus remarkably reduced the incidence of spinal induced hypotension compared to the non-treatment group. We recommend prophylactic phenylephrine for parturients undergoing caesarean section under spinal anaesthesia. Moreover, other pharmacological and non-pharmacological methods need to be considered as the incidence of hypotension is still high in the treatment group.

Keywords: Caesarean section; Spinal anesthesia; Hypotension; Apgar score; Phenylephrine Prophylaxis; Effectiveness

Introduction

Spinal anaesthesia is a widely used anaesthetic technique for caesarean as it avoids the risks of general anesthesia related to difficult intubation and aspiration of gastric contents [1-3]. Spinal anesthesia in pregnant women is associated with greater incidence of hypotension (80%) observed in non-pregnant women despite the preloaded or coloaded fluid [4].

Post spinal hypotension remains common despite several measures used to reduce both incidence and severity [5,6] of subarachnoid block and it is decrement of systemic blood pressure due to systemic vasodilation secondary to sympathetic blockade by intrathecal administration of local anaesthetics. Hypotension can be defined as reduction of blood pressure by 20% from base line or systolic blood pressure 7-9]. A reduction in systemic vascular resistance as a consequence of sympathetic blockade, extensive neural blockade because of a contracted subarachnoid space, higher level of sympathetic block and aorthocaval compression by gravid uterus, as well as to the already low decreased systemic vascular resistance associated with pregnancy [10,11].

The effect of spinal anesthesia on fetal heart rate is due to maternal hypotension and subsequent fetal hypoxia. Maternal hypotension of 80 mmHg for five min almost always results in hypoxic fetal bradycardia [12,13]. The severity of post spinal hypotension will be more aggravated and ended up with many detrimental clinical effects [14-18]. Various pharmacologic and non pharmacologic [[19,20] methods have been used to prevent, treat and decrease adverse effects of post spinal anaesthesia hypotension [20-22]. However, non-pharmacologic mechanisms are associated with high incidence of high spinal block and unilateral block especially when hyperbaric local anaesthetics are used [23]. As pharmacologic methods, are associated with hemodynamic instability (refractive hypertension, bradycardia, and tachycardia) and fetal acid base disturbance and uterine vasoconstriction [24-26], other modalities such as fluid administration, left lateral position and trendelenburg positions should be considered [27,28].

Many studies are conducted to determine effective drugs to prevent and control hypotension such as ephedrine, phenylephrine, adrenaline, metaraminol, and dopamine [29-35]. However, there is no known gold standard drug for prevention and control of post spinal hypotension. Furthermore, Cochrane review of 75 trials (4,624 women) different hypotension prevention methods showed that crystalloids were less effective than colloids but more effective than no fluid in preventing hypotension following spinal anaesthesia at caesarean section. Ephedrine and phenylephrine when given individually were more effective than crystalloids or controls in preventing hypotension but no significant differences in hypotension were seen between ephedrine and phenylephrine [36].

Although, non-pharmacologic methods are alternatives, hypotension during spinal anaesthesia common and almost all parturients required vasopressor for intervention [37]. Phenylephrine is a selective α1-adrenergic receptor agonist which has been used to increase blood pressure. Because of its sympathomimetic effect without beta-adrenergic activity, it does not increase contractility force and output of cardiac muscle; it may increase BP resulting in a slow heart rate through stimulation of vascular baroreceptors as reflex bradycardia is side effect of its IV administration [38,39]. Phenylephrine used as alternative vasopressor for treatment and prevention of post spinal hypotension. Some studies showed different results to choose the best drug during cesarean delivery under spinal anesthesia but associated with some side effects such as hypertension and bradycardia [40].

Recently, phenylephrine is introduced in our hospital to treat spinal anaesthesia induced hypotension using different dose regimens (50 μgm, 100 μgm). However, its efficacy on the prevention of spinal anaesthesia induced hypotension remains unexplored in our hospital. We aimed to assess the effectiveness of prophylactic intravenous phenylephrine bolus on the prevention of spinal anaesthesia induced hypotension in parturients undergoing caesarean section.

Methods

Institutional based prospective observational study was conducted in University of Gondar Hospital from May 1-30, 2017. The University of Gondar Hospital is one of the largest referral and teaching hospitals in the Amhara region and serving around 5 million people. Postspinal hypotension is being routinely managed by fluid and available vasoconstrictors (phenylephrine, adrenaline) as prophylaxis or treatment by anaesthetists during operation.

Study population

All mothers who gave birth by caesarean section in University of Gondar Hospital during the study period.

Inclusion and exclusion criteria

All ASAI and ASAII parturients who underwent cesarean section under spinal anaesthesia (parturients who took phenylephrine prophylaxis or who didn’t take any prophylactic vasoconstrictor). Patient refusal, massive obstetric hemorrhage, complicated surgery (such as hysterectomy), myocardial infarction of <3 months, parturients who have allergic history for phenylephrine, failed spinal or total spinal converted to general anesthesia were excluded from the study.

Variables of the study

Dependent variable

The incidence of hypotension, maternal hemodynamic change (HR and BP) at different time intervals in the intraoperative and postoperative period (0-1 h), Apgar score at 1 and 5th min were compared among participants with and without prophylactic phenylephrine.

Independent variables

Socio-demographic variables (age, weight, height) indication for caesarian section, parity, gestational age, duration of surgery, time from skin incision to delivery of fetus, ASA category, the amount of fluid preloaded or coloaded, level of SA block (sensory and motor), type and dose of local anesthetics given.

Operational definitions

Hypotension: Decrease in systolic blood pressure from baseline by 20-25% [41,42].

Post spinal hypotension (PSH): Reduction of systolic blood pressure from baseline by 20% following spinal anesthesia [43,44].

Bradycardia: Reduction of heart rate to <60 bpm [45].

Tachycardia: Increment of heart rate >100 bpm by whatever the cause [46].

Hypertension: Elevation of blood pressure more than 140/90 mmHg and it could sometimes be resistant for treatment [47].

Nausea and vomiting: Sense of discomfort, hyper salivation or vomiting ingested matter or any content after any surgical or anesthetic intervention [48].

Effectiveness of phenylephrine: It is the ability of the drug to decrease incidence of hypotension and it could be assessed by blood pressure change after it has given.

Safety of phenylephrine: It is assessed by change in heart rate (bradycardia), blood pressure (hypertension) and neonatal outcome (Apgar) score.

Sample size and sampling procedure

All consecutive laboring mothers (prospectively) who delivered by cesarean section under spinal anaesthesia during the study period were included in the study.

Data collection procedures

Ethical approval was obtained from University of Gondar, School of Medicine ethical review board (Ref.No. SOM /1004/4/2017). Written informed consent was obtained from study participants before commencing the study. Recently, phenylephrine is introduced in our hospital for the prevention of spinal anaesthesia induced hypotension with different dose regimens (50 μgm and 100 μgm). Parturients who underwent caesarean section were classified in to three groups: phenylephrine 50 μgm, phenylephrine 100 μgm and none prophylaxis group based on their exposure (treatment by the responsible anaesthetists). Phenylephrine IV bolus was given immediately after spinal anaesthesia (after a patient is positioned). We investigators did not involve in the perioperative management of patients). Pulse rate, non-invasive blood pressure (NIBP), peripheral oxygen saturation (SPO2) were measured before, immediately after spinal anaesthesia, every 2 min intra operatively till delivery of the baby and then every 5 min after delivery for 20 min and every 10 min for 1 h in postoperative period. Anaesthetic management including prophylactic phenylephrine was up to the choice of the responsible anaesthetists. The data collector observed the responsible anaesthetist whether he or she gave vasoconstrictors during administration of spinal anaesthesia. Mothers who took bolus dose of phenylephrine and who were not taking drug were identified by the data collector (Figure 1).

anesthesia-clinical-research-groups-CONSORT-flow

Figure 1: CONSORT flow diagram for patient allocation.

The data collector continuously observed the hemodynamic variables of parturients, intraoperative anaesthetic and surgical interventions, and Apgar score during the study period without having place in intervention in whatever the case. Level of sensory block was assessed and recorded by pinprick after completion of spinal anaesthesia. Motor block was assessed and recorded by Bromage motor scale. Total amount of intraoperative fluid, estimated blood loss, doses of drugs for treatment of hypotension and duration of surgery were recorded by one of the data collector.

Data analysis

After completion of data collection, the data were checked for errors and coded. The coded data were entered to SPSS version 20.0 statistical package and analysis was performed. Numerical variables were analyzed using independent student t-test and Man-Whitney U test as appropriate. Incidence of hypotension was compared using chi-square test. P value <0.05 was considered statistically significant. Numerical data were presented as mean ± Standard deviation or median (IQR) and categorical data as proportions (%). Baseline characteristics and risk level were checked for similarity in the groups.

Results

Socio-demographic characteristics of study participants

A total of 113 parturients were given spinal anaesthesia. One patient was excluded because spinal anaesthesia failed and converted to general anaesthesia and other two patients are excluded due to missing data. All (110) laboring mothers who underwent caesarean delivery under spinal anaesthesia during the study period were included. The indications for caesarean section were cephalopelvic disproportion 20 (18.2%), non-reassuring fetal heart rate 22 (20%), failed induction 18 (16.4%), previous caesarean section scar 21 (19.1%), malpresentation 17 (14.5%), mild antepartum hemorrhage 5 (4.5%), and others (oligo/ polyhydramnios, PROM) 7 (6.4%).

All patients have been premeditated with 10mg metoclopramide and 200 mg cimetidine. Of these patients, 50 mothers were given prophylactic phenylephrine (37 patients=50 micrograms and 13 patients=100 micrograms) immediately after spinal anaesthesia with 2.5 ml of 0.5% plain bupivacaine and 60 were not given any prophylactic drug. The demographic characteristics (age, height, weight, gestational age) were comparable between the groups (Table 1). Regarding with ASA physical status, 30.9% of prophylactic group and 36.4% of non-prophylactic group were ASA I while 14.5% of prophylactic group and 18.2% of non-prophylactic group were ASA II. Concerning parity, 32.7% in prophylactic group and 40.9% in non-prophylactic group were para II and below, 12.7% in prophylactic group and 13.6% in non-prophylactic group were para III and above (Table 1).

Group Prophylactic given (n=50) Prophylactic not given (n=60) p-value
Age in years 27.6 ± 3.844 28.13 ± 5.061 0.542
Weight in kilograms 63.38 ± 10.57 63.58 ± 6.298 0.901
Height in centimeters 159.96 ± 5.32 158.76 ± 4.42 0.225
Gestational age in weeks 38.26 ± 1.38 38.23 ± 0.88 0.907
ASA Class   0.882
     I 34 (30.9%) 40 (36.4%)  
    II 16 (14.5%) 20 (18.2%)  
Parity   0.431
  Para ≤ II 36 (32.7%) 45 (40.9%)  
   Para>II 14 (12.7%) 15 (13.6%)  
Values are presented as: Mean ± SD, Number (%), student t-test, chi-square and p<0.05 is statistically significant.

Table 1: Comparison of socio-demographic variables between groups.

Variables related to anaesthesia and surgery

The amounts of fluid given preoperatively, at the time of incision to delivery of the baby, duration of surgery, estimated blood loss were comparable between groups (Table 2). Baseline vital signs (systolic BP, diastolic BP, heart rate and saturation) were not significantly different between groups (Table 2).

Characteristics Prophylaxis given (n=50) Prophylaxis not given (n=60)  P-value
Baseline systolic BP 121.34 ± 7.91 122.11 ± 7.20 0.591
Baseline diastolic BP 75.28 ± 6.35 76.75 ± 6.23 0.225
Baseline heart rate 91.34 ± 6.07 90.45 ± 6.37 0.458
Baseline saturation 97.16 ± 1.67 96.98 ± 2.05 0.628
Amount of fluid given preoperatively (ml) 500 (500) 700 (500) 0.184
Incision starting time to delivery of baby (min) 8.5 (4) 10 (1.75) 0.311
Estimated blood loss (ml) 600 (112.5) 600 (100) 0.965
Duration of surgery (min) 50 (15) 50 (15) 0.183
Values are presented as:  Mean ± SD, Median (IQR), independent student t-test, Mann Whitney u test and p<0.05 is statistically significant.

Table 2: Comparison of baseline vital signs, factors associated with surgery and anaesthesia between groups.

The incidence of hypotension

The incidence of hypotension between participants who took prophylactic phenylephrine and those who didn’t take the drug was different. Of 50 participants who took phenylephrine (50 or 100 microgram) only 13 (26%) had 1 or more episodes of hypotension, whereas of 60 participants who didn’t take any prophylactic drug 49 (81.6%) developed hypotension episodes (P<0.001) (Figure 2).

anesthesia-clinical-research-groups-Incidence-hypotension

Figure 2: Incidence of hypotension between groups.

When the incidence of hypotension compared between the doses of prophylactic drug; from 37 parturients who took 50 μg phenylephrine, 13 (35%) developed hypotension whereas no parturient developed hypotension from those 13 parturients who took 100 μg phenylephrine (p=0.012) (Table 3). The levels of block (sensory and motor block) were comparable between groups (Table 3).

Parameter Prophylactic given (n=50) Prophylactic not given (n=60) p-value
Level of sensory block   0.074
       T4-T6 13 (11.8%) 28 (25.4%)  
       T7-T8 21 (19.0%) 20 (18.1%)  
       T9-T10 16 (14.5%) 12 (10.9%)  
Level of Motor block   0.999
       Bromage 2 0 (0%) 1 (0.9%)  
       Bromage3 50 (45.4%) 59 (53.6%)  
Incidence of hypotension between prophylactic phenylephrine dose regimens
Prophylactic  dose 50 µg 100 µg P-value
Incidence of hypotension 13 (35%) 0 (0%) 0.013
Treatment of  hypotension between groups
                                               Prophylactic No prophylactic  
Dose of drug for treatment of hypotension 25 µgm (25)a 25 µgm (10)a 0.005
Total amount of fluid (preop+ intraop, ml) 1500 (100)a 1500 (300)a <0.001
Values are presented as: number (%); a=median (IQR), chi-square test and p<0.05 is statistically significant.

Table 3: Comparison of level of block (sensory and motor) between groups, incidence of hypotension between two prophylactic phenylephrine doses.

Due to this, the dose of drugs for treatment of hypotension (phenylephrine for phenylephrine group and adrenaline for non-phenylephrine group) and amount of fluid given intraoperatively were more needed for those participants with no prophylactic drug as it is statistically significant with p-value of 0.005 and <0.001 respectively (Table 3).

Intraoperative vital sign changes overtime and neonatal outcome

Blood pressure (systolic and diastolic), pulse rate and saturation were observed every 2 min of time interval starting from immediate time after SA till delivery, at delivery and every 5 min after delivery for 20 min. Systolic and diastolic blood pressure immediately after SA till delivery of the baby were significantly lower in those without prophylactic drug (P<0.001) all the time (Table 4). In addition, the blood pressure (systolic and diastolic) was significantly lower during the intraoperative period including the whole time after delivery despite different treatment modalities as it was shown by p-value of less than 0.05. Even though the blood pressure was not expected to be lower at immediate period after SA, it could be due to the autonomic effect of SA anaesthesia which usually starts at this time. However, pulse and were not significantly different throughout intraoperative period between the groups (Table 4).

  Systolic blood pressure Diastolic blood pressure Heart rate
Parameter intraoperatively Prophylactic given Prophylactic not given P-value Prophylactic given Prophylactic not given P-value Prophylactic given Prophylactic not given P-value
Immediately after SA 111.50 ± 17.36 89.86 ± 10.99 0.001 65.02 ± 12.67 52.83 ± 9.07 0.001 99.74 ± 15.55 94.71 ± 17.44 0.117
2 min 110.00  ± 15.75 91.83 ± 11.49 0.001 65.16 ± 12.75 56.58 ± 10.22 0.001 94.52 ± 19.63 95.98 ± 15.35 0.662
4 min 106.46  ± 13.36 90.93 ± 11.12 0.001 64.38 ± 11.76 53.18 ± 9.42 0.001 92.32 ± 14.56 94.01 ± 12.85 0.518
6 min 108.98 ± 15.15 91.33 ± 12.51 0.001 65.48 ± 11.71 53.85 ± 10.57 0.001 92.68 ± 12.83 93.38 ± 11.73 0.765
8 min 107.88 ± 14.68 91.38 ± 11.78 0.001 63.92 ± 11.67 53.50 ± 10.19 0.001 88.44 ± 17.63 92.53 ± 12.65 0.172
10 min 109.34 ± 12.78 93.36 ± 11.35 0.001 64.52 ± 10.86 54.33 ± 9.94 0.001 91.02 ± 12.8 91.98 ± 10.79 0.669
12 min 110.76 ± 12.91 94.43 ± 12.33 0.001 64.82 ± 11.82 56.85 ± 9.96 0.001 89.96 ± 12.21 90.26 ± 14.54 0.906
At delivery 108.58  ± 13.24 95.36 ± 10.56 0.001 66.38 ± 11.30 58.46 ± 9.13 0.001 90.50 ±  13.11 90.01 ±  11.33 0.836
5 min 111.7  ± 12.41 98.23 ± 11.20 0.001 66.72 ± 11.80 60.60 ± 8.53 0.003 89.94 ± 13.15 88.65 ± 11.58 0.586
10 min 112.82 ± 11.82 101.00 ± 10.61 0.001 68.48 ± 11.18 61.48 ± 7.92 0.001 87.76 ± 9.66 88.30 ± 11.57 0.794
15 min 113.62 ± 12.25 102.01 ± 9.64 0.001 68.74 ± 10.38 62.63 ± 7.62 0.001 88.40 ± 9.55 88.70 ± 10.86 0.879
20 min 112.5  ± 11.37 102.43 ± 9.43 0.001 69.54 ± 10.42 62.98 ± 6.80 0.001 86.92 ± 9.99 88.06 ± 8.96 0.522
Values are presented as: Mean ± SD, student t-test and P-value <0.05 statistically significant.

Table 4: Comparison of intraoperative SBP, DBP and heart rate before and after delivery.

Neonatal outcome was comparable between groups as it is computed by Apgar score of 1st and 5th min which were not significantly different. However, the overall number of hypotension episodes and number of treatments (rescue) given for hypotension were significantly higher in those who didn’t take prophylactic phenylephrine (Table 5).

Parameter Prophylactic given (n=50) Prophylactic not given (n=60) p-value
APGAR score at 1 min 8 (1) 8 (1) 0.911
APGAR score at 5 min 10 (1) 10 (1) 0.087
Number of hypotension episodes 3.30 ± 1.49 8.30 ± 2.11 <0.001
Number of treatments for hypotension 1.16 ± 0.38 2.80 ± 1.24 <0.001
Values are presented as:  Mean ± SD, Median (IQR), independent student t-test, Mann Whitney u test and p<0.05 is statistically significant.

Table 5: Comparison of outcome variables related to neonatal outcome, number of hypotension episodes and number of treatments for hypotension.

Postoperative vital sign changes overtime

Vital signs (blood pressure, pulse rate and saturation) were measured and observed starting from immediate postoperative period for 1 h. Systolic blood pressure was significantly different between groups at immediate post-operative period, at 20th min and 30th min (P<0.001). Diastolic blood pressure was significantly lower for those participants with no prophylaxis at most of the times in post-operative period except at immediate pot-operative period till 10th min post-operatively. Whereas pulse rate and saturation were was comparable during post-operative period between groups No patient has developed vomiting despite those many episodes of hypotension during intraoperative and post-operative period (Table 6).

  Systolic blood pressure Diastolic blood pressure Pulse rate
Parameter at post-op period Prophylactic given Prophylactic not given p-value Prophylactic given Prophylactic not given p-value Prophylactic given Prophylactic not given p-value
Immediate post- operative  period 113.18 ± 9.78 106.58 ± 10.24 0.001 70.48 ± 8.82 68.90 ± 10.9 0.414 85.80 ± 9.94 85.05 ± 13.01 0.739
10 min 111.9 ± 8.76 108.55 ± 10.49 0.075 70.84 ± 8.63 69.18 ± 8.97 0.329 84.08 ± 8.91 83.11 ± 12.24 0.644
20 min 114.40 ± 7.46 108.80 ± 8.57 0.001 71.84 ± 7.68 68.40 ± 8.00 0.024 85.68 ± 7.91 82.70 ± 11.1 0.113
30 min 116.84 ± 7.10 110.23 ± 9.08 0.001 74.56 ± 6.48 71.83 ± 6.86 0.036 84.74 ± 8.01 83.03 ± 11.06 0.365
40 min 115.32 ± 7.95 111.78 ± 9.38 0.683 74.82 ± 7.30 71.31 ± 8.12 0.020 83.24 ± 7.43 82.53 ± 9.94 0.679
50 min 116.14 ± 7.07 112.61 ± 9.22 0.134 75.34 ± 6.81 72.31 ± 7.44 0.030 84.52 ± 7.03 81.61 ± 7.03 0.086
60 min 117.14 ± 6.45 113.51 ± 7.40 0.267 76.22 ± 7.61 73.00 ± 6.84 0.021 84.54 ± 7.03 81.35 ± 9.96 0.050
Values are presented as:  Mean± SD, Median (IQR), independent student t-test and p<0.05 is statistically significant.

Table 6: Comparison of systolic BP, diastolic BP and pulse rate at postoperative period.

Discussion

Hypotension is the most common complication of spinal anaesthesia. The incidence of spinal anesthesia induced hypotension is reported to be as high as 80% [4]. It can have detrimental effects on both the mother and fetus. The adverse effects include decrease in uteroplacental blood flow, impaired fetal oxygenation with distress, fetal acidosis and maternal symptoms of low cardiac output such as nausea, vomiting, dizziness, and decreased consciousness to the mother [4].

In this study, the incidence of hypotension was high (81.6%) in those parturients who did not take prophylactic phenylephrine than those who took prophylactic phenylephrine (26%). The intraoperative blood pressure (systolic and diastolic) stayed lower significantly all intraoperative period in those with no prophylactic phenylephrine, whereas, there was no significant difference in pulse rate and saturation in the intraoperative and postoperative period between the groups. Even though the sensory and motor onset of SA starts around after 5 min, its autonomic effect is expected to start immediately after SA which is evidenced by significant hypotension in those without prophylaxis at earlier times after spinal anaesthetic injection. Moreover, the blood pressure was significantly different in some time intervals between groups, despite different hypotension management methods used. The neonatal outcome was comparable between groups as it was evidenced by Apgar score of 1st and 5th min.

In our study, the incidence of hypotension without prophylactic phenylephrine was high (81.6% vs. 26%) compared with none of the treatment group. This finding was low compared with a study conducted by Ayorinde B et al. where the incidence of hypotension in phenylephrine group was 33% whereas it was 70% in placebo group. This discrepancy could be due to the route of administration in which they used intramuscular phenylephrine unlike our study where IV administration used [49].

In this study, the incidence of hypotension in prophylactic phenylephrine group was low (26%) compared with a study conducted by Warwick D et al. that the incidence of hypotension without prophylactic drug was high (88%) whereas 23% in those who received prophylactic phenylephrine infusion [29]. This difference could be due to they used continuous infusion of phenylephrine rather than single bolus which could decrease the incidence of hypotension.

Hypotension remains a common and serious complications following spinal anesthesia despite different preventive measures have been applied such as preloading, positioning and left uterine displacement. The result of this study shows that the intraoperative systolic and diastolic blood pressures were significantly lower in patients with no prophylactic phenylephrine compare to phenylephrine prophylactic group. Our finding was in accordance with a study conducted by Farnaz Moslemi et al. in Iran, in which the incidence of hypotension despite prophylactic phenylephrine was 28.5%. However, a review study by Habib et al. on efficacy of phenylephrine infusion revealed that, the incidence of hypotension after prophylaxis was 13-23% and the intraoperative blood pressure was well maintained [1,50]. This could be due to weight adjusted continuous infusion with no significant fluctuation of blood pressure, which is impossible in single bolus unless rescue treatment doses given.

In our study, the Apgar score at 1st and 5th min was >7 in both groups. This finding was comparable with another study [31,51]. However, in our study, the intraoperative pulse rate was not significantly different between those groups with prophylactic phenylephrine and without prophylaxis unlike another study where higher incidence of bradycardia with 100 mg bolus phenylephrine was reported. This discrepancy could be due to the small dose (50 μgm) used in our study for the majority of parturients. Furthermore, it is supported by another systematic review on 7 trials in which the Apgar score at 1st and 5th min was >7 [31,51].

The incidence of hypotension was significantly lower in this study unlike other studies with bolus phenylephrine, could be due to the application of the hypotension definition for earlier times after spinal anaesthesia given in which time the drug is expected to be effective. Even though the prophylaxis controls hypotension at earlier time after administration, there were many hypotension episodes in the intraoperative period which were clinically significant. The number of hypotension episodes intraoperatively differs significantly between groups (P<0.001).

Limitation and Strength of the Study

This is not a randomized control trial study as our university ethical board prohibited RCT by graduate students. Inter-anaesthetist practice variation such as preoperative optimization, intraoperative management including speed of injection of local anaesthetics, level of the block, timing of administration of phenylephrine prophylaxis, the dose of vasoconstrictor drugs etc, could possibly affect the outcome of the study.

This is the first study in our hospital which could enhance the use of prophylactic phenylephrine for the prevention of spinal anaesthesia induced hypotension for parturients undergoing caesarean section.

Conclusion And Recommendation

The incidence of spinal anaesthesia induced hypotension was high. Prophylactic intravenous bolus phenylephrine remarkably reduced the incidence of spinal induced hypotension compared to the non-treatment group. In addition, no parturient developed hypotension among who received 100 μgm phenylephrine. We recommend prophylactic phenylephrine (100 μgm) for parturients undergoing caesarean section under spinal anaesthesia. Moreover, other pharmacological and non-pharmacological methods need to be considered to optimally manage spinal anaesthesia induced hypotension as the incidence of hypotension was still high in phenylephrine treated group. Furthermore, we recommend RCT study in this hospital and other similar settings in the country with large cohort of patients.

Acknowledgement

We are grateful to the University of Gondar for financial support (for MSc thesis in Advanced Clinical Anaesthesia).

References

  1. Habib AS (2012) A review of the impact of phenylephrine administration on maternal hemodynamics and maternal and neonatal outcomes in women undergoing cesarean delivery under spinal anesthesia. Anesth Analg 114: 377-390.
  2. Mwaura LW, Mung'ayi V, Kabugi J1, Mir S (2016) A randomized control trial comparing weight adjusted dose versus fixed dose prophylactic phenylephrine infusion on maintaining systolic blood pressure during caeserean section under spinal anaesthesia. Afr Health Sci 16: 399-341.
  3. Brenck F, Hartmann B, Katzer C, Obaid R, Brüggmann D, et al. (2009) Hypotension after spinal anesthesia for cesarean section: identification of risk factors using an anesthesia information management system. J Clin  Monit Comput 23: 85-92.
  4. Hennebry MC, Stocks GM, Belavadi P, Barnes J, Wray S, et al. (2009) Effect of i.v. phenylephrine or ephedrine on the ED50 of intrathecal bupivacaine with fentanyl for caesarean section.  Br J Anaesth 102: 806-811.
  5. Allen T, George R, White W,  Muir H, Habib A (2011) A Double-blind, Placebo-controlled Trial of 4 Fixed Rate Infusion Regimens of Phenylephrine for Hemodynamic Support During Spinal Anesthesia for Cesarean Delivery. Obst Anesth Dig 31: 204.
  6. Kee WDN, Khaw KS, Ng FF (2005) Prevention of Hypotension during Spinal Anesthesia for Cesarean DeliveryAn Effective Technique Using Combination Phenylephrine Infusion and Crystalloid Cohydration. Anesthesiology 103: 744-750.
  7. Kee WDN, Lee SW, Ng FF, Tan PE, Khaw KS (2015) Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. Anesthesiology 122: 736-745.
  8. Singh J, Singh P, Agarwal A, Ahuja P (2015) To Compare the Efficacy of Intramuscular Phenylephrine and Ephedrine In LSCS to avoid Post Spinal Hypotension. J Evol  Med Dent Sci 2015 4: 3247-3523.
  9. Bishop D, Cairns C, Grobbelaar M, Rodseth R (2017) Heart rate variability as a predictor of hypotension following spinal for elective caesarean section: a prospective observational study. Anaesthesia 72: 603-608.
  10. Stewart A, Fernando R, McDonald S, Hignett R, Jones T, et al. (2010) The dose-dependent effects of phenylephrine for elective cesarean delivery under spinal anesthesia. Anesth Analg 111: 1230-1237.
  11. Sakata K, Yoshimura N, Kito K, Tanabe K, Iida H (2016)  Prediction of Hypotension During Spinal Anesthesia for Cesarean Section By Heart Rate Variability. Anesth Analg 123: 273.
  12. Lee J, George RB, Habib AS (2017) Spinal induced hypotension: incidence, mechanisms, prophylaxis and management: summarizing 20 years of research. Best Pract Res Clin Anaesthesiol 57-68.
  13. Bishop DG (2014) Predicting spinal hypotension during Caesarean section. Afr J Anaesth Analg 20: 170-173.
  14. Hanss R, Bein B, Ledowski T, Lehmkuhl M, Ohnesorge H, et al. (2005) Heart rate variability predicts severe hypotension after spinal anesthesia for elective cesarean delivery. Anesthesiology 102: 1086-1093.
  15. Kannaujia AK, Shamshery C, Bhowmik A (2016) Vasopressin infusion during combine spinal epidural anesthesia for cesarean section in a patient with severe mitral stenosis with pulmonary hypertension. E J Anaesth 32: 143-145.
  16. Mercier FJ1, Augè M, Hoffmann C, Fischer C, Le Gouez A (2013) Maternal hypotension during spinal anesthesia for caesarean delivery. Minerva Anestesiol 79: 62-73.
  17. Unlugenc H, Turktan M, Evruke IC, Gunduz M, Burgut R, et al. (2015) Rapid Fluid Administration and the Incidence of Hypotension Induced By Spinal Anesthesia and Ephedrine Requirement: The Effect of Crystalloid versus Colloid Coloading. Middle East J Anaesthesiol 23: 273-281.
  18. Chiang CF, Hasan MS, Tham SW, Sundaraj S, Faris A (2017) Injection speed of spinal anaesthesia for Caesarean delivery in Asian women and the incidence of hypotension: A randomised controlled trial. J  Clin Anesth 39: 82-86.
  19. Bagle AA, Vishnu A, Kumar A, Malik A, Garg V (2017) Evaluation of leg wrapping for the prevention of postspinal hypotension in cesarean section under spinal anesthesia. Anesth Essays Res 11: 439-443.
  20. Heesen M, Klimek M, Hoeks SE, Rossaint R (2016) Prevention of Spinal Anesthesia-Induced Hypotension During Cesarean Delivery by 5-Hydroxytryptamine-3 Receptor Antagonists: A Systematic Review and Meta-analysis and Meta-regression. Anesth Analg 123: 977-988.
  21. Sng BL, Tan HS, Sia AT (2014) Closed-loop double-vasopressor automated system vs manual bolus vasopressor to treat hypotension during spinal anaesthesia for caesarean section: a randomised controlled trial. Anaesthesia 69: 37-45.
  22. Melchor JR, Espinosa Á, Hurtado EM, Francés RC, Pérez RN, et al. (2015) Colloids versus crystalloids in the prevention of hypotension induced by spinal anesthesia in elective cesarean section. A systematic review and meta-analysis. Minerva Anestesiol 81: 1019-1030.
  23. Kinsella SM (2003) Lateral tilt for pregnant women: why 15 degrees? Anaesthesia 58: 835-836.
  24. Hasanin A, Mokhtar AM, Badawy AA, Fouad R (2017) Post-spinal anesthesia hypotension during cesarean delivery, a review article. Eg J Anaesth 33: 189-193.
  25. Mohta M, Aggarwal M, Sethi A, Harisinghani P, Guleria K (2016) Randomized double-blind comparison of ephedrine and phenylephrine for management of post-spinal hypotension in potential fetal compromise. Int J Obstet Anesth 27: 32-40.
  26. Lal SK, Rathore SN (2015) Comparison of Phenylephrine versus Ephedrine for Management of Hypotension during Spinal Anaesthesia for Elective Caesarean Section. I J Public Health Res  Dev 6: 34-39.
  27. Chen J, Lan Q, Jin S, Zeng X, Zhan H (2016) Administration of Vasoconstrictor, but not Volume Ex-pander Prevents Maternal Hypotension during Spinal-Epidural Anesthesia for Elective Cesarean Section. SAJ Cas Rep 3: 102.
  28. Ngan Kee WD (2017) The use of vasopressors during spinal anaesthesia for caesarean section. Curr Opin Anaesthesiol 30: 319-325.
  29. Kee WDN, Khaw KS, Ng FF, Lee BB (2004) Prophylactic phenylephrine infusion for preventing hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 98: 815-821.
  30. Saravanan S, Kocarev M, Wilson RC, Watkins E, Columb MO, et al. (2006) Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section. Br J Anaesth 96: 95-99.
  31. Lee A, Kee WDN, Gin T (2002) A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 94: 920-926.
  32. Kee WDN, Lau TK, Khaw KS, Lee BB (2001) Comparison of metaraminol and ephedrine infusions for maintaining arterial pressure during spinal anesthesia for elective cesarean section. Anesthesiology 95: 307-313.
  33. Jang Y-E, Do S-H, Song I (2013) Vasovagal cardiac arrest during spinal anesthesia for Cesarean section-A case report. Korean J Anesthesiol 64: 77-81.
  34. Morgan P (1994) The role of vasopressors in the management of hypotension induced by spinal and epidural anaesthesia. Can J Anaesth 41: 404-413.
  35. Khaw KS, Kee WDN, Lee SW (2006) Hypotension during spinal anaesthesia for caesarean section: implications, detection prevention and treatment. Fetal  Matern Med Rev 17: 157-183.
  36. Cyna AM, Andrew M, Emmett RS, Middleton P, Simmons SW. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev 18: CD002251.
  37. Gunda CP, Malinowski J, Tegginmath A, Suryanarayana VG, Chandra SB (2010) Vasopressor choice for hypotension in elective Cesarean section: ephedrine or phenylephrine? Arch Med Sci 6: 257-263.
  38. Poterman M, Vos JJ, Vereecke HE, Struys MM, Vanoverschelde H, et al. (2015) Differential effects of phenylephrine and norepinephrine on peripheral tissue oxygenation during general anaesthesia: a randomised controlled trial. Eur J Anaesthesiol 32: 571-580.
  39. Kuhn JC, Hauge TH, Rosseland LA, Dahl V, Langesæter E (2016) Hemodynamics of Phenylephrine Infusion Versus Lower Extremity Compression During Spinal Anesthesia for Cesarean Delivery: A Randomized, Double-Blind, Placebo-Controlled Study. Anesth Analg 122: 1120-1129.
  40. Kee WN, Khaw K, Ng F (2004) Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for Caesarean section. Br J Anaesth 92: 469-474.
  41. Hirsch J, DePalma G, Tsai TT, Sands LP, Leung JM (2015) Impact of intraoperative hypotension and blood pressure fluctuations on early postoperative delirium after non-cardiac surgery. Br J Anaesth 115: 418-426.
  42. Gabriella V, Amelia F, Michael D, Bruno G, Antonio M, et al. (2016) Renal Guard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Eurointervention 11: e1658-1661.
  43. Kansal A, Mohta M, Sethi AK, Tyagi A, Kumar P (2005) Randomised trial of intravenous infusion of ephedrine or mephentermine for management of hypotension during spinal anaesthesia for Caesarean section. Anaesthesia  60: 28-34.
  44. Siddiqui AS, Salim B, Siddiqui SZ (2015) Comparison of phenylephrine and ephedrine for treating hypotension after spinal anesthesia for cesarean section: A Randomized double-blind clinical trial. Anaesth Pain Inten Care 19: 44-49.
  45. Sahu D, Kothari D, Mehrotra A (2003) Comparison of bolus phenylephrine, ephedrine and mephentermine for maintenance of arterial pressure during spinal anaesthesia in caesarean section-a clinical study. Indian J Anaesth 47: 125-128.
  46. Olshansky B, Shen WK, Calkins H, Brignole M, Olshansky B, et al. (2015) Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 12: e41-e63.
  47. Zanchetti A (2014) Challenges in hypertension: prevalence, definition, mechanisms and management. J  Hypertens 32: 451-453.
  48. Chan A, Kim HK, Hsieh RK, Yu S, de Lima Lopes G, et al. (2015) Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice-a longitudinal analysis. Support Care Cancer 23: 283-291.
  49. Ayorinde BT1, Buczkowski P, Brown J, Shah J, Buggy DJ (2001) Evaluation of pre-emptive intramuscular phenylephrine and ephedrine for reduction of spinal anaesthesia-induced hypotension during Caesarean section. Br J Anaesth 86: 372-376.
  50. Moslemi F, Rasooli S (2015) Comparison of prophylactic infusion of phenylephrine with ephedrine for prevention of hypotension in elective cesarean section under spinal anesthesia: A randomized clinical trial. Iran J Med Sci 40: 19-26.
  51. Nazir I, Bhat MA, Qazi S, Buchh VN, Gurcoo SA (2012) Comparison between phenylephrine and ephedrine in preventing hypotension during spinal anesthesia for cesarean section J Obstet Anaesth Crit Care 2: 92-97.
Citation: Agegnehu AF, Gebreegzi AH, Lemma GF, Endalew NS, Gebremedhn EG (2017) Effectiveness of Intravenous Prophylactic Phenylephrine for the Prevention of Spinal Anaesthesia Induced Hypotension during Caesarean Section. A Prospective Observational Study. J Anesth Clin Res 8: 779.

Copyright: © 2017 Agegnehu AF, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top